Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 29.04.2024 4 BMC Neurol 3 Diabetes 9 Diabetes Res Clin Pract 3 Intern Med 3 J Autoimmun 3 J Clin Endocrinol Metab 1 J Immunol 1 J Neuroimmunol 3 J Neurol 1 J Pediatr Endocrinol Metab 2 Lancet 3 Mult Scler 6 Neurology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. UZAWA A, Suzuki S, Kuwabara S, Akamine H, et al
   Taste disorders and alopecia in myasthenia gravis.
   BMC Neurol. 2024;24:139.
   PubMed         Abstract available
   
   
2. ZHONG R, Chen X, Liao F, Lin Z, et al
   FLAMES overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review.
   BMC Neurol. 2024;24:140.
   PubMed         Abstract available
   
   
3. SELLITTO G, Ruotolo I, Ianniello A, Felicetti F, et al
   Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
   BMC Neurol. 2024;24:138.
   PubMed         Abstract available
   
   
4. HU S, Lin Z, Liu T, Huang S, et al
   Guillain-Barre syndrome following scrub typhus: a case report and literature review.
   BMC Neurol. 2024;24:137.
   PubMed         Abstract available
   
   

   
   Diabetes

5. CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al
   CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.
   Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588.
   PubMed         Abstract available
   
   
6. CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al
   An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.
   Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
   PubMed         Abstract available
   
   
7. TANG Y, Ang L, Jaiswal M, Dillon BR, et al
   Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.
   Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

8. TATULASHVILI S, Dreves B, Meyer L, Cosson E, et al
   Carbohydrate counting knowledge and ambulatory glucose profile in persons living with type 1 diabetes.
   Diabetes Res Clin Pract. 2024;210:111592.
   PubMed         Abstract available
   
   
9. CITRO F, Bianchi C, Aragona M, Belcari T, et al
   Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes.
   Diabetes Res Clin Pract. 2024;210:111611.
   PubMed         Abstract available
   
   
10. GUPTA A, Mukherjee S, Kumar Bhadada S, Ram S, et al
    Impact of short-term application of continuous glucose monitoring system(CGMS) on long-term glycemic profile in adolescents and adults with type 1 diabetes mellitus: An open-label randomized control cross over study.
    Diabetes Res Clin Pract. 2024;210:111610.
    PubMed         Abstract available
    
    
11. RASBACH L, Purrington G, Adkins D, Benjamin R, et al
    Innovations: Using telemedicine to improve care of predominantly non-white youth with suboptimal insulin dependent diabetes control.
    Diabetes Res Clin Pract. 2024;210:111613.
    PubMed         Abstract available
    
    
12. MARIGLIANO M, Lanzinger S, Zineb I, Barcala C, et al
    The role of sex on the prevalence of cardiovascular risk factors in children and adolescents with Type 1 diabetes: The SWEET international database.
    Diabetes Res Clin Pract. 2024;210:111616.
    PubMed         Abstract available
    
    
13. MOTTL AK, Tryggestad JB, Isom S, Gubitosi-Klug RA, et al
    Major adverse events in youth-onset type 1 and type 2 diabetes: The SEARCH and TODAY studies.
    Diabetes Res Clin Pract. 2024;210:111606.
    PubMed         Abstract available
    
    
14. CHERUBINI V, Fargalli A, Arnaldi C, Bassi M, et al
    Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study.
    Diabetes Res Clin Pract. 2024;210:111621.
    PubMed         Abstract available
    
    
15. PARENT C, Lespagnol E, Berthoin S, Tagougui S, et al
    Continuous moderate and intermittent high-intensity exercise in youth with type 1 diabetes: Which protection for dysglycemia?
    Diabetes Res Clin Pract. 2024;210:111631.
    PubMed         Abstract available
    
    
16. BERTHON W, McGurnaghan SJ, Blackbourn LAK, Mellor J, et al
    Ongoing burden and recent trends in severe hospitalised hypoglycaemia events in people with type 1 and type 2 diabetes in Scotland: A nationwide cohort study 2016-2022.
    Diabetes Res Clin Pract. 2024;210:111642.
    PubMed         Abstract available
    
    

    
    Intern Med

17. SAITO S, Hontsu S, Hiraoka J, Yamanaka A, et al
    A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3028.
    PubMed         Abstract available
    
    
18. NAKANOH H, Takeuchi H, Shiho M, Terajima Y, et al
    Successful treatment for life threatening recurrent non-traumatic rectus sheath hematoma in a case with microscopic polyangiitis with rapidly progressive glomerulonephritis.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3239.
    PubMed         Abstract available
    
    
19. TAJIRI K
    Immune Checkpoint Inhibitor Myotoxicities: An Autoimmune Perspective.
    Intern Med. 2024 Apr 23. doi: 10.2169/internalmedicine.3700.
    PubMed        
    
    

    
    J Autoimmun

20. DO JS, Arribas-Layton D, Juan J, Garcia I, et al
    The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
    J Autoimmun. 2024;146:103228.
    PubMed         Abstract available
    
    
21. CHUANG HC, Lan KY, Hsu PM, Chen MH, et al
    UHRF1P contributes to IL-17A-mediated systemic lupus erythematosus via UHRF1-MAP4K3 axis.
    J Autoimmun. 2024;146:103221.
    PubMed         Abstract available
    
    
22. ESEN I, Sandovici M, Heeringa P, Boots AMH, et al
    Impaired IL-6-induced JAK-STAT signaling in CD4(+) T cells associates with longer treatment duration in giant cell arteritis.
    J Autoimmun. 2024;146:103215.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

23. TSAITLIN-MOR L, Cahen-Peretz A, Bentov Y, Ben-Shushan T, et al
    Long-Term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad715. doi: 10.1210.
    PubMed         Abstract available
    
    
24. HOOPER AJ
    Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
    J Clin Endocrinol Metab. 2023 Dec 11:dgad719. doi: 10.1210.
    PubMed        
    
    
25. WU HX, Chu TY, Iqbal J, Jiang HL, et al
    Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2023 Dec 9:dgad720. doi: 10.1210.
    PubMed        
    
    

    
    J Immunol

26. TAO Q, Chen Y, Liang Q, Shi J, et al
    Puerarin Alleviates Experimental Autoimmune Thyroiditis by Regulating Macrophages.
    J Immunol. 2024 Apr 26:ji2300779. doi: 10.4049/jimmunol.2300779.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

27. LI V, Binder MD, Purcell AW, Kilpatrick TJ, et al
    Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis.
    J Neuroimmunol. 2024;390:578347.
    PubMed         Abstract available
    
    

    
    J Neurol

28. ROSENSTEIN I, Nordin A, Sabir H, Malmestrom C, et al
    Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.
    J Neurol. 2024 Apr 26. doi: 10.1007/s00415-024-12389.
    PubMed         Abstract available
    
    
29. FONTE J, Stabile A, de Curtis M, Di Giacomo R, et al
    Seizures in autoimmune-associated epilepsy: a long-term video-EEG monitoring study.
    J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12385.
    PubMed        
    
    
30. NAUTA IM, van Dam M, Bertens D, Kessels RPC, et al
    Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
    J Neurol. 2024 Apr 23. doi: 10.1007/s00415-024-12327.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

31. YAZKAN AKGUL G, Koprulu O
    Examination of quality of life and psychiatric symptoms in childhood Graves' disease.
    J Pediatr Endocrinol Metab. 2024 Apr 22. doi: 10.1515/jpem-2023-0550.
    PubMed         Abstract available
    
    

    
    Lancet

32. KRICKAU T, Naumann-Bartsch N, Aigner M, Kharboutli S, et al
    CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis.
    Lancet. 2024 Apr 17:S0140-6736(24)00424-0. doi: 10.1016/S0140-6736(24)00424.
    PubMed        
    
    
33. HOI A, Igel T, Mok CC, Arnaud L, et al
    Systemic lupus erythematosus.
    Lancet. 2024 Apr 17:S0140-6736(24)00398-2. doi: 10.1016/S0140-6736(24)00398.
    PubMed         Abstract available
    
    

    
    Mult Scler

34. MANUEL AM, Gottlieb A, Freeman L, Zhao Z, et al
    Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.
    Mult Scler. 2024 Apr 25:13524585241240398. doi: 10.1177/13524585241240398.
    PubMed         Abstract available
    
    
35. BIANCHI A, Cortese R, Prados F, Tur C, et al
    Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
    Mult Scler. 2024 Apr 22:13524585241240420. doi: 10.1177/13524585241240420.
    PubMed         Abstract available
    
    
36. NOVAK F, Bajwa HM, Ostergaard K, Berg JM, et al
    Extended interval dosing with ocrelizumab in multiple sclerosis.
    Mult Scler. 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.
    PubMed         Abstract available
    
    

    
    Neurology

37. VALKO Y, Wirth MA, Fierz FC, Schesny MK, et al
    Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Neurology. 2024;102:e209395.
    PubMed         Abstract available
    
    
38. LIAO J, Lu Y, Lu Y, Huang Y, et al
    Cardiopulmonary Coupling Spectrogram as an Ambulatory Method for Assessing Sleep Disorders in Patients With Autoimmune Encephalitis.
    Neurology. 2024;102:e209302.
    PubMed         Abstract available
    
    
39. MICHAELSON NM
    Right Brain: The Unraveling.
    Neurology. 2024;102:e209492.
    PubMed         Abstract available
    
    
40. VYAS MV, Kapral MK, Alonzo R, Fang J, et al
    Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in Permanent Immigrants.
    Neurology. 2024;102:e209350.
    PubMed         Abstract available
    
    
41. SILBERMANN E, Spain RI
    Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too Late?
    Neurology. 2024;102:e209456.
    PubMed        
    
    
42. FOX RJ, Cree BAC, de Seze J, Gold R, et al
    Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209357.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.